SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-111159
Filing Date
2020-10-01
Accepted
2020-10-01 17:17:44
Documents
15
Period of Report
2020-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032255d1_8k.htm   iXBRL 8-K 32962
2 EXHIBIT 10.1 tm2032255d1_ex10-1.htm EX-10.1 119523
3 EXHIBIT 99.1 tm2032255d1_ex99-1.htm EX-99.1 10073
7 GRAPHIC tm2032255d1_ex99-1img01.jpg GRAPHIC 5247
  Complete submission text file 0001104659-20-111159.txt   383092

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cara-20201001.xsd EX-101.SCH 3210
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20201001_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20201001_pre.xml EX-101.PRE 22726
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2032255d1_8k_htm.xml XML 3729
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 201217091
SIC: 2834 Pharmaceutical Preparations